GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nihon Kohden Corp (TSE:6849) » Definitions » Capex-to-Revenue

Nihon Kohden (TSE:6849) Capex-to-Revenue : 0.02 (As of Mar. 2024)


View and export this data going back to 1961. Start your Free Trial

What is Nihon Kohden Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Nihon Kohden's Capital Expenditure for the three months ended in Mar. 2024 was 円-1,506.00 Mil. Its Revenue for the three months ended in Mar. 2024 was 円65,817.00 Mil.

Hence, Nihon Kohden's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.02.


Nihon Kohden Capex-to-Revenue Historical Data

The historical data trend for Nihon Kohden's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nihon Kohden Capex-to-Revenue Chart

Nihon Kohden Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.01 0.04 0.02

Nihon Kohden Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.03 0.02 0.02 0.02

Competitive Comparison of Nihon Kohden's Capex-to-Revenue

For the Medical Devices subindustry, Nihon Kohden's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nihon Kohden's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nihon Kohden's Capex-to-Revenue falls into.



Nihon Kohden Capex-to-Revenue Calculation

Nihon Kohden's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4786) / 221986
=0.02

Nihon Kohden's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1506) / 65817
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nihon Kohden  (TSE:6849) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Nihon Kohden Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nihon Kohden's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nihon Kohden (TSE:6849) Business Description

Traded in Other Exchanges
Address
31-4 Nishiochiai 1-chome, Shinjuku-ku, Tokyo, JPN, 1618560
Nihon Kohden Corp manufactures electronic medical equipment. The firm operates in four categories: physiological measuring equipment, treatment equipment, patient monitors, and other medical equipment. The patient monitors segment contributes the largest proportion of revenue and includes continuous monitoring instruments and clinical information systems. The physiological measuring equipment segment sells electroencephalographs, electrocardiographs, and diagnostic information systems. The treatment equipment segment sells defibrillators, pacemakers, ventilators, and related consumables. The other medical equipment segment sells automated hematology analyzers, ultrasound diagnostic equipment, and other laboratory equipment. Nihon Kohden generates the majority of its revenue in Japan.

Nihon Kohden (TSE:6849) Headlines

No Headlines